they may soon be used to treat liver disease, cardiovascular conditions, sleep apnea and even reduce cancer risk
Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenics
Research shows clear benefits: Better stability than oral delivery, which exposes peptides to harsh stomach conditions Less breakdown by enzymes that would destroy the peptide before it reaches the blood Easier compliance no needles, no mixing, just spray Potential for targeted delivery to specific tissues, including the brain via the olfactory pathway Nasal delivery works very well for peptides like BPC-157 that target the whole body
Abdollahi M, Ranjbar A, Shadnia S, Nikfar S, Rezaie A
PT-141 should not be injected more than twice a week or eight times per month, Staheli cautions